Tim Walbert, Horizon Pharma’s Chairman, President, CEO, and iBIO’s Chairman was featured by Medical, Marketing, and Media. The article focuses on how Tim’s experience as a patient shaped Horizon Pharma’s dedication to the patients that they serve and their focus on bringing new therapies to the market for rare diseases.
“There are about 7,000 rare diseases today, and there are only treatments for 5% of them,” he explains. “So many of those diseases are essentially ignored because of the size of the patient population, and that’s not acceptable. The more we talk about this, even if it’s sometimes in a negative light, the more we can drive awareness.”
Read the full article here.